Graves disease: latest understanding of pathogenesis and treatment options
Crossref DOI link: https://doi.org/10.1038/s41574-024-01016-5
Published Online: 2024-07-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lanzolla, Giulia
MarinĂ², Michele
Menconi, Francesca http://orcid.org/0000-0003-2100-3123
Text and Data Mining valid from 2024-07-22
Version of Record valid from 2024-07-22
Article History
Accepted: 20 June 2024
First Online: 22 July 2024
Competing interests
: M.M. is a member of the Advisory Board of Horizon Pharma. The other authors declare no competing interests.